+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Spinraza 2017 U.S. Promotional Audit Report

  • ID: 4616012
  • Report
  • Region: United States
  • 21 pages
  • MD Details
1 of 2
The 5 Key Questions Addressed by this Report:
  • How many physicians were reached by Spinraza through reportable promotional activity in 2017 to drive use within the Spinal Muscular Atrophy market?
  • What promotional mix was leveraged (e.g., sales rep detailing, physician education, and paid speaking) and what was the median spend for each type of activity?
  • How does Biogen's depth of coverage vary within key specialties (e.g., Neurology, Pediatric Medicine, Physical Medicine and Rehabilitation, and Diagnostic Radiology) and how does this compare to the overall set of rep-accessible physicians?
  • How often are physicians receiving paid meals for Spinraza throughout the year (e.g., monthly, quarterly, annually)?
  • Who were the most frequent meal recipients and top paid speakers for Spinraza in 2017?
Data Sources and Methodology:
  • The author leverages company-reported financial transaction data disclosed through CMS Open Payments. This data set captures all transfers of value (e.g., speaking fees, consulting fees, travel, education, and meals) made on behalf of a drug or device manufacturer to a physician. More than four years of longitudinal data is available - covering payments to more than 975,000 U.S. healthcare professionals.
  • Over 700 paid interactions across 400 physicians made on behalf of Spinraza were carefully examined to support our analysis.
Note: Product cover images may vary from those shown
2 of 2


3 of 2
Note: Product cover images may vary from those shown
Order Online - visit: https://www.researchandmarkets.com/reports/4616012